Showing results (1-10 of 121) with videos related to
Sort By:
Pageof 13
Cancer Cytopathology|May 13, 2015
Molecular markers: Implications for cytopathology and specimen collectionPaul A VanderLaanCancer Cytopathology|May 17, 2016
Fine-needle aspiration and core needle biopsy: An update on 2 common minimally invasive tissue sampling modalitiesPaul A VanderLaanJournal of the American Society of Cytopathology|May 23, 2020
Collection and Handling of Thoracic Small Biopsy and Cytology Specimens for Ancillary Studies Guideline from the College of American Pathologists (CAP): implications for the cytology communityPaul A VanderLaanJournal of the American Society of Cytopathology|November 10, 2021
Molecular testing results as a quality metric for evaluating cytopathologists' utilization of the atypia of undetermined significance category for thyroid nodule fine-needle aspirationsPaul A VanderLaan, Michiya NishinoCancer Cytopathology|September 5, 2020
Current and future trends in non-small cell lung cancer biomarker testing: The American experiencePaul A VanderLaan, Sinchita Roy-ChowdhuriJournal of Lipid Research|March 18, 2005
Thematic review series: the immune system and atherogenesis. The unusual suspects:an overview of the minor leukocyte populations in atherosclerosisPaul A Vanderlaan, Catherine A ReardonCancer Cytopathology|August 30, 2018
Pre-analytic error: A significant patient safety riskYael K Heher, Yigu Chen, Paul A VanderLaanAmerican Journal of Clinical Pathology|September 16, 2011
Usefulness of diagnostic qualifiers for thyroid fine-needle aspirations with atypia of undetermined significancePaul A VanderLaan, Ellen Marqusee, Jeffrey F KraneAmerican Journal of Clinical Pathology|April 20, 2011
Clinical outcome for atypia of undetermined significance in thyroid fine-needle aspirations: should repeated fna be the preferred initial approach?Paul A VanderLaan, Ellen Marqusee, Jeffrey F KranePageof 13